Sessioni Comunicazioni Orali


Ketamine and Pharmacology of pshychiatric diseases

Saturday, October 28th / 9.00-11.00
60KETAMINE INDUCED STRUCTURAL PLASTICITY IN HUMAN IPSC-DERIVED DOPAMINERGIC NEURONS
Collo G., Cavalleri L., Millan MJ., Chiamulera C., Spano PF., Merlo pich E.
61POST-SYNAPTIC GLUTAMATE DYSFUNCTION INDUCED BY KETAMINE SELF-ADMINISTRATION
Caffino L., Piva A., Mottarlini F., Giannotti G., Di chio M., Venniro M., Yew DT., Chiamulera C., Fumagalli F.
62METAPLASTIC TREATMENTS WITH KETAMINE AND MK-801 AFFECT INSTRUMENTAL APPETITIVE MEMORY RECONSOLIDATION IN RATS
Gerace E., Piva A., Di chio M., Padovani L., Pellegrini-giampietro DE., Chiamulera C.
63THE MULTIPLE EFFECTS OF THE KETAMINE ANALOG METHOXETAMINE: PRECLINICAL EVIDENCE
Fattore L., Zanda MT., Mutti A., Fratta W., Chiamulera C.
64Ketamine modulation of PSD gene expression: implication for pathophysiology and treatment of behavioral disorders
65Dopamine D3 receptors control dysbindin-dependent executive functions alterations relevant to schizophrenia
Leggio GM., Torrisi SA., Managò F., Chisari M., Mastrogiacomo R., Mereu M., De luca MA., Ciranna L., Salomone S., Drago F., Papaleo F.
66Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: role of 5-HT2A receptor agonism
Scarselli M., Aringhieri S., Kolachalam S., Carli M.
67EFFECTS OF THE PPAR-ALPHA AGONIST FENOFIBRATE IN AN IMMUNE-MEDIATED NEURODEVELOPMENTAL MODEL OF PSYCHOSIS
Pistis M., Sagheddu C., Aroni S., Muntoni AL., Frau R., Fanni S., Pardu A., Devoto P., Melis M., De felice M.